Skip to content

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
DexCom logo
DexComDXCM
35.6%+11.9pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-65.7%-14.7pp
AdaptHealth logo
AdaptHealthAHCO
-5.2%-10.8pp
CTS Corporation logo
CTS CorporationCTS
12.6%+1.7pp

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Calculated from Senseonics Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's return on equity?
Senseonics Holdings, Inc. (SENS) reported return on equity of -250.7% in Q1 2026.
How has Senseonics Holdings, Inc. 's return on equity changed year-over-year?
Senseonics Holdings, Inc. 's return on equity increased by 8.2% year-over-year, from -273.2% to -250.7%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.